Crop Life Science Balance Sheet Health
Financial Health criteria checks 3/6
Crop Life Science has a total shareholder equity of ₹403.9M and total debt of ₹268.2M, which brings its debt-to-equity ratio to 66.4%. Its total assets and total liabilities are ₹1.0B and ₹643.3M respectively. Crop Life Science's EBIT is ₹92.6M making its interest coverage ratio 3.8. It has cash and short-term investments of ₹13.7M.
Key information
66.4%
Debt to equity ratio
₹268.23m
Debt
Interest coverage ratio | 3.8x |
Cash | ₹13.66m |
Equity | ₹403.85m |
Total liabilities | ₹643.31m |
Total assets | ₹1.05b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CLSL's short term assets (₹884.7M) exceed its short term liabilities (₹576.3M).
Long Term Liabilities: CLSL's short term assets (₹884.7M) exceed its long term liabilities (₹67.1M).
Debt to Equity History and Analysis
Debt Level: CLSL's net debt to equity ratio (63%) is considered high.
Reducing Debt: Insufficient data to determine if CLSL's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: CLSL's debt is not well covered by operating cash flow (3.7%).
Interest Coverage: CLSL's interest payments on its debt are well covered by EBIT (3.8x coverage).